Microbicides 2002: An update

AIDS Patient Care and STDs

Volumn 16, Issue 9, 2002, Pages 419-430

  Johnston, Rowena ^a  

^a Amer Foundation for AIDS Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BELGIUM; ECONOMIC ASPECT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; POLITICS; REVIEW; SEXUAL TRANSMISSION; SOCIAL ASPECT; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; BELGIUM; HIV INFECTIONS; HUMANS; SEXUALLY TRANSMITTED DISEASES, VIRAL;

EID: 0036741873     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729102760330263     Document Type: Review

References (47)

1. Joint United Nations Programme on HIV/AIDS Web site. AIDS epidemic update. Available at: www.unaids.org/worldaidsday/2001/Epiupdate2001/Epiupdate2001_en.pdf. Accessed June 3, 2002.
2. UN Foundation Announces Partnership with Netherlands Embassy in New Delhi. United Nations Foundation News, March 8, 2002.
3. Ramasundaram S. Can India avoid being devastated by HIV? BMJ 2002;324:182-183.
4. Zhang KL, Ma SJ. Epidemiology of HIV in China: Intravenous drug users, sex workers, and large mobile populations are high-risk groups. BMJ 2002;324:803-804.
5. Gross M, Mayer K, Roehr B. Creating a research and development agenda for rectal microbicides that protect against HIV infection. Creating a Research and Development Agenda for Rectal Microbocides that Protect Against HIV. Amfar, New York, NY 2001;3-4.
6. Watts C, Kumaranayake L, Vickerman P, Terris-Prestholt F. New hope for HIV prevention: Projections of the impact of microbicides. Microbicides 2002 Conference Abstract 2002;68.
7. Researchers: More money needed to complete antiAIDS, STDs gels. May 3, 2002. Associated Press.
8. Joint United Nations Programme on HIV/AIDS Web site. UNAIDS calls for continued commitment to microbicides. Available at: www.unaids.org/whatsnew/press/eng/pressarc00/durban120700.html. Accessed June 12, 2002.
9. Richardson B. Nonoxynol-9 as a vaginal microbicide for prevention of sexually transmitted infections: It's time to move on. JAMA 2002;287:1171-1172.
10. Malkovsky M, Newell A, Dalgleish AG. Inactivation of HIV by nonoxynol-9. Lancet 1988;1:645.
11. Wilkinson D, Ramjee G, Rutherford G. Nonoxynol-9 spermicide for prevention of HIV and other sexually transmitted infections: Systematic review and metaanalysis of randomised controlled trials. Microbicides 2002 Conference Abstract 2002;5.
12. Buve A, Carael M, Hayes RJ et al. Multicentre study on factors determining differences in rate of spread of HIV in sub-Saharan Africa: methods and prevalence of HIV infection. AIDS 2001;15(Suppl 4):S5-14.
13. Mauck C, Weiner D, Creinin M, Barnhart K, Callahan M, Bax R. Single and multiple exposure tolerance study of three concentrations of C31G: Once- and twice-daily exposure. Microbicides 2002 Conference Abstract 2002;34.
14. Bergeron MG, Omar RF, Desmormeaux A, Gagnon MT, Vezina F, Trottier S. Phase I clinical trial to evaluate the safety and acceptability of the Invisible Condom™ when applied intravaginally to healthy female subjects. Microbicides 2002 Conference Abstract 2002;36.
15. Kazmi S, Sattentau Q. Mechanisms of inhibition of HIV-1 attachment and entry. Microbicides 2002 Conference Abstract 2002;25.
16. Low-Beer N, Jespers V, McCormack S et al. A safety study of dextrin sulphate gel as a novel vaginal microbicide: Data from HIV negative and positive women. Microbicides 2002 Conference Abstract 2002;119.
17. Kilmarx PH, Witwatwongwana P, van de Wijgert J et al. Incidence of irritation and genital lesions in a year-long, randomized, controlled clinical trial of a carrageenan gel as a vaginal microbicide. Microbicides 2002 Conference Abstract 2002;37.
18. Coetzee N, Hoosen A, Blanchard K et al. A randomized, placebo-controlled double-blind safety trial of Carraguard™ microbicide gel in South Africa: Signs and symptoms of genital irritation. Microbicides 2002 Conference Abstract 2002;34.
19. Bukenya M, Pickering J, Okong P, Byaruhanga R, Lacey C, Whitworth J. A phase II study of the safety of dextrin sulphate gel in sexually active females in Kampala. Microbicides 2002 Conference Abstract 2002;33.
20. Jespers V, Van Damme L, Chapman A. Penile application of dextrin sulphate gel (Emmeller®) to HIV+ve and HIV-ve men. Microbicides 2002 Conference Abstract 2002;38.
21. Callahan M. Safety and tolerance studies of potential microbicides following multiple penile applications. Microbicides 2002 Conference Abstract 2002;41.
22. Hillier S, Murray P, Marrazzo J, Krohn M, Wiesenfeld H. Sexual behaviors of women enrolled in a microbicide trial of Lactobacillus crispatus CTV 05 in the United States. Microbicides 2002 Conference Abstract 2002;39.
23. Berger E. A novel HIV-1 neutralization protein based on sequential receptor interactions: Potential use as a topical microbicide against sexual transmission. Microbicides 2002 Conference Abstract 2002;20.
24. Lusso P, Longhi R, Sironi F, Rizzi M, Pavone V. Mapping of the HIV-inhibitory determinants of chemokines as a strategy for the rational design of novel antiviral molecules. Microbicides 2002 Conference Abstract 2002;14.
25. Moore J. Novel entry inhibitors. Microbicides 2002 Conference Abstract 2002;23.
26. Velasco J, Zeitlin L, Whaley K. Production of a panel of anti-HIV monoclonal antibodies in corn: Plantibodies™ for a vaginal HIV-specific microbicide. Microbicides 2002 Conference Abstract 2002;79.
27. Margolis L. Coreceptor use ex vivo. Microbicides 2002 Conference Abstract 2002;27.
28. Wira C, Fahey J, Wallace P, Yeaman G. Mucosal immunity in the female reproductive tract. Microbicides 2002 Conference Abstract 2002;19.
29. Hladik F. Immunity in the female genital tract. Microbicides 2002 Conference Abstract 2002;29.
30. Kaul R, Thottingal P, Kiama P, et al. The role of mucosal immunity in HIV-1 susceptibility and transmission. Microbicides 2002 Conference Abstract 2002;6.
31. Taylor S, Sadiq ST, Weller I, Drake S, Back D, Pillay D. HIV-1 drug penetration into the male genital tract: Implications for sexual transmission. Microbicides 2002 Conference Abstract 2002;24.
32. Harrison P. Products in the pipeline: Overview, change, lessons and implications. Microbicides 2002 Conference Abstract 2002;52.
33. Holt BY, Ngo L, Harrison P, et al. The market potential for microbicides: Young US women. Microbicides 2002 Conference Abstract 2002;62.
34. Halperin DT. Heterosexual anal intercourse: Prevalence, cultural factors, and HIV infection and other health risks, Part I. AIDS Patient Care STDS. 1999;13:717-730.
35. Veazey R. SIV in the anorectal system. Microbicides 2002 Conference Abstract 2002;28.
36. Royce RA, Sena A, Cates W, Cohen MS. Sexual transmission of HIV. N Engl J Med 1997;336:1072-1078.
37. Mauck C. Colposcopy. Microbicides 2002 Conference Abstract 2002;51.
38. Black R. Preclinical and clinical safety - A critical review. Microbicides 2002 Conference Abstract 2002;7.
39. Van den Mooter G. The formulation of vaginal microbicides. Microbicides 2002 Conference Abstract 2002;5.
40. Barnhart KT, Pretorius ES, Malamud D. Non-invasive imaging of the spread of microbicides with magnetic resonance imaging. Microbicides 2002 Conference Abstract 2002;49.
41. Katz D. Measurement, analysis and interpretation of vaginal gel coating distribution in women. Microbicides 2002 Conference Abstract 2002;49.
42. Tambwekar K, Gunjan R, Vermani K, Kandarapu R, Zaneveld LJD, Garg S. Effect of different bioadhesive polymers on performance characteristics of vaginal tablets. Microbicides 2002 Conference Abstract 2002;15.
43. Delany S, Mullick S, Bekinska M, Rees H. Douching and dry sex: Sexual hygiene practices amongst female sex workers and family planning clients in Johannesburg, South Africa. Microbicides 2002 Conference Abstract 2002;166.
44. Vickerman P, Watts C, Heise L et al. Determinants of microbicide impact: Model predictions from two African settings. Microbicides 2002 Conference Abstract 2002;67.
45. Foss A, Vickerman P, Phil D, Heise L, Watts C. Migration from the condom: Should we be concerned? Microbicides 2002 Conference Abstract 2002;66.
46. Mishkin A. Potential market for microbicides. Microbicides 2002 Conference Abstract 2002;69.
47. Kumaranayake L. Ensuring microbicide access: Public/private toles in low and middle income countries. Microbocides 2002 Conference Abstracts 2002;68.